An investigation into the source of the deglutamated metabolites of methotrexate in patients treated with high dose infusions.
D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D007262:Infusions, Intravenous; D002955:Leucovorin / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D008727:Methotrexate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000188:drug therapy; D010084:Oxidation-Reduction
C000203:deoxyaminopteroic acid; D002955:Leucovorin; D008727:Methotrexate